The TTS Young Investigator Scientific awards are designed to help offset expenses incurred to attend the TTS Congress and are awarded based on the scientific merit of applicants. Therefore, recipients must attend the meeting in order to receive the grant. If an awardee is selected for a scientific award, but do not attend the meeting, the monies of the award will be forfeited.
- 550.3Penelope Allen, Australia
The impact of recurrent glomerulonephritis after kidney transplantation in the era of contemporary maintenance immunosuppression - 453.1Vaishnavi Calisa, Australia
The relative costs and health benefits of an age-matched deceased donor allocation algorithm compared to current practice - 358.2Aravind Cherukuri, United States
Early de novo DSA with T Cell Mediated Rejection (TCMR) is Associated with Allograft Dysfunction with Chronic Injury - 329.8Jason Davis, United States
Changes in liver allograft steatosis and its impact on early graft function and long term survival - 355.2Denis Efimov, Belarus
DAMP-associated preservation injury and complications after liver transplantation: proof of concept - 425.6Shaimaa Elkholy, Egypt
Predictors of Mortality In Living Donor Liver Transplantation - 451.5Jianing Fu, United States
Generation of naïve donor-derived lymphocytes from graft-resident lymphoid progenitors after human intestinal transplantation - 329.13Barbara Kern, Austria
Nonalcoholic Steatohepatitis as Indication for Liver Transplantation in Europe. Clinical Analysis of over 37.000 Patients. - 322.1Qiang Liu, United States
Triglyceride exportation in the preservation of discarded steatotic human livers using 24 hours ex-vivo normothermic machine perfusion - 355.1David Nasralla, United Kingdom
A Multicentre Randomised Controlled Trial to Compare the Efficacy of Normothermic Machine Perfusion with Static Cold Storage in Human Liver Transplantation: Early Outcomes - 625.2Kevin Tak-Pan Ng, Hong Kong SAR, P.R. of China
Up-regulation of GSTA2 at early-phase after liver transplantation increases the risk of late-phase hepatocellular carcinoma recurrence - 424.1Thomas Schachtner, Germany
Kinetics of CMV-specific T-cells From Pre-to-Posttransplantation Predict Outcomes in CMV-seronegative Kidney Transplant Recipients
- 422.1Oscar Serrano, United States
Defining the tipping point in surgical performance in laparoscopic donor nephrectomy during abdominal transplant surgery fellowship: a learning curve analysis. - 550.4Rashmi Shingde, Australia
Trojan Kidneys: Unexpected Donor-Derived Viral Transmission in Kidney Transplant Recipients – a Systematic Review - 456.9Umang Thakkar, India
Stem cell therapy as an emerging modality for post-traumatic paraplegia and for renal parenchymal diseases - 626.3Mirjam Tielen, Netherlands
Importance of Early Medication Adherence for Long-Term Graft Survival: A Prospective, Single-Centre Cohort Study - 556.2Thomas Vanhove, Belgium
Tubulointerstitial expression of connective tissue growth factor in renal allograft protocol biopsies at 3 months predicts interstitial fibrosis at 5 years - 451.6Georgios Vrakas, United Kingdom
De Novo Donor-Specific HLA Antibodies after Combined Intestinal and Vascularized Composite Allotransplantation - 427.2Johannes Wedel, United States
DEPTOR modulates alloimmunity by increasing regulatory T cell function and stabilizing Foxp3 expression - 428.3Cheng Yang, People’s Republic of China
Cyclic Helix B Peptide Inhibits Ischemia Reperfusion-induced Renal Fibrosis via the PI3K/Akt/FoxO3a Pathway - 625.1Wai Ho Oscar Yeung, Hong Kong SAR, P.R. of China
Dysregulation of transforming growth factor beta receptor III induces tumor promoting macrophages via complement C3a in Hepatocellular Carcinoma recurrence after liver transplantation
